Results 161 to 170 of about 148,802 (383)

Living With Chronic Rhinosinusitis: Insights From an Arts‐Based Study

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Background Chronic rhinosinusitis (CRS) significantly reduces quality of life (QoL), but data regarding the extent of its impact is sparse. Questionnaire‐based assessments of QoL may neglect aspects of complex patient experiences. Recent studies on asthma patients and other chronic conditions have used self‐expression through artwork to better
Jenny Xiao, Masih Sarafan, Julie Zhu, Béatrice Voizard, Andrew Vernu Thamboo   +4 more
wiley   +1 more source

Round table discussion on gastroesophageal reflux disease

, 1978
Rekha Goyal, Castell Do, Jette Christensen, Steven B. Cohen, C. E. Pope   +4 more
openalex   +1 more source

Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate‐to‐Severe Atopic Dermatitis

Allergy, EarlyView.
Data were included from adolescents with moderate‐to‐severe AD treated with the JAK1 inhibitor abrocitinib (200 mg/100 mg) across JADE clinical trials. Improvements in skin clearance (per EASI‐75) and itch (per PP‐NRS4) were maintained for up to 112 weeks with both abrocitinib doses.
Amy S. Paller, Lawrence F. Eichenfield, Alan D. Irvine, Carsten Flohr, Andreas Wollenberg, Sébastien Barbarot, Christine Bangert, Jonathan M. Spergel, Andrew Selfridge, Pinaki Biswas, Haiyun Fan, Justine Alderfer, Melissa Watkins, Herwig Koppensteiner   +13 more
wiley   +1 more source

Oral alterations associated to gastroesophageal reflux disease

Revista Cubana de Estomatología, 2020
Introduction: Gastroesophageal reflux disease is a functional multifactorial disorder of the upper gastrointestinal tract. Oral alterations are considered to be extraesophageal manifestations of this disease.
Yulisa Otero Baxter, Carlos Jesús Llapur Almaguer, Maritza Osorio Nuñez, Edelis Raimundo Padrón   +3 more
doaj  

Pathophysiology of Gastroesophageal Reflux and Distal Esophageal Motility in Children with Gastroesophageal Reflux Disease

, 1988
Salvatore Cucchiara, Annamaria Staiano, C Di Lorenzo, G. De Luca, A. della Rocca, Salvatore Auricchio   +5 more
openalex   +1 more source

Silent Gastroesophageal Reflux Disease

Journal of Neurogastroenterology and Motility, 2012
Gastroesophageal reflux disease (GERD) is defined as the presence of acid-reflux-related symptoms, or esophageal mucosal damage, caused by the reflux of gastric contents into the esophagus.1 The diagnosis of GERD can therefore be easily made by patients' complaint of typical (heartburn and regurgitation) and/or atypical acid-reflux-related symptoms ...
openaire   +4 more sources

LASTEN GASTROESOFAGEAALINEN REFLUKSITAUTI : Vanhempien kokemuksia hoitohenkilökunnalta saamastaan ohjauksesta ja tuesta [PDF]

, 2015
Opinnäytetyömme tarkoituksena oli kuvata gastroesofageaalista refluksitautia sairastavien lasten vanhempien kokemuksia hoitohenkilökunnalta saamastaan ohjauksesta ja tuesta, sekä selvittää, millaista ohjausta ja tukea vanhemmat olisivat ...
Perkiö, Jennika, Vauhkala, Johanna
core  

Gastrointestinal Barrier Disruption in Post‐COVID Syndrome Fatigue Patients

Allergy, EarlyView.
Gastrointestinal (GI) barrier disruption in the context of SARS‐CoV‐2 infection is associated with the development of Post‐COVID Syndrome (PCS) Fatigue. Pre‐existing GI complaints may predispose to fatigue development. Monitoring GI symptoms and markers before, during, and after SARS‐CoV‐2 infection is crucial for identifying predictive clinical ...
Johanna Rohrhofer, Viktoria Wolflehner, Johannes Schweighardt, Larissa Koidl, Michael Stingl, Sonja Zehetmayer, Joana Séneca, Petra Pjevac, Eva Untersmayr   +8 more
wiley   +1 more source

Mepolizumab Effectiveness in Severe Asthma With/Without Chronic Rhinosinusitis With Nasal Polyps: Real‐World Pooled Analysis

Allergy, EarlyView.
MEPOLYP was a pooled analysis of 1037 patients with SAEP[±]CRSwNP. Mepolizumab was associated with a reduction in CSEs, OCS use, and BEC, and improved lung function and ACT score. Over 47% of patients fulfilled ≥ 3 clinical remission criteria. When compared, there was a 30.0% incremental benefit of mepolizumab in reducing CSEs for patients with SAEP ...
Florence Schleich, Stelios Loukides, Rekha Chaudhuri, Joerg D. Leuppi, Enrico Heffler, Cristian Domingo, Claudio Micheletto, Thomas Paulsson, Nina Gaw, Konstantina Kallinikou, Carla Vossen, Florent Guelfucci, Jyothi Menon, Armel Ngami, Ines Palomares   +14 more
wiley   +1 more source

Obesity and gastroesophageal reflux disease and gastroesophageal reflux symptoms in children

Clinical and Experimental Gastroenterology, 2009
Hoda M Malaty1, J Kennard Fraley1,2, Suhaib Abudayyeh1, Kenneth W Fairly1, Ussama S Javed1, et al1Department of Medicine, 2Children’s Nutrition Research Center (CNRC), 4Department of Pediatrics, 5Texas Children’s Hospital, Baylor ...
Hoda M Malaty, J Kennard Fraley, Suhaib Abudayyeh, Kenneth W Fairly, Ussama S Javed, et al   +4 more
doaj